Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
Exelixis
Exelixis
Medical College of Wisconsin
Immatics US, Inc.
University of California, San Francisco
Centre Georges Francois Leclerc
Oncovir, Inc.
Celldex Therapeutics